Abdelaziz AO, Abdelhalim H, Elsharkawy A, Shousha HI, Abdelmaksoud AH, Soliman ZA, Seif MI, Sayed DB, Farouk MH, Elbaz TM, Nabeel MM (2019) Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study. Eur J Gastroenterol Hepatol 31(6):685–691. https://doi.org/10.1097/MEG.0000000000001343

Article  PubMed  Google Scholar 

Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O (2020) New frontiers in liver resection for hepatocellular carcinoma. JHEP Reports. https://doi.org/10.1016/j.jhepr.2020.100134

Article  PubMed  PubMed Central  Google Scholar 

Bedossa P (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20(1):15–20. https://doi.org/10.1002/HEP.1840200104

Article  Google Scholar 

Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24(2):289–293. https://doi.org/10.1002/HEP.510240201

Article  CAS  PubMed  Google Scholar 

Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, Petta S, Thiele M (2021) EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis—2021 update. J Hepatol 75(3):659–689. https://doi.org/10.1016/j.jhep.2021.05.025

Article  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 68(6):394–424. https://doi.org/10.3322/CAAC.21492

Article  Google Scholar 

Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, Ercolani G, Festi D, Pinna AD (2012) Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Annal Surg. https://doi.org/10.1097/SLA.0B013E3182724CE8

Article  Google Scholar 

Child CG, Turcotte JG (1964) Surgery and portal hypertension. Major Probl Clin Surg 1:1–85

CAS  PubMed  Google Scholar 

Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepatitis 14(5):360–369. https://doi.org/10.1111/J.1365-2893.2006.00811.X/ABSTRACT

Article  CAS  Google Scholar 

Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229(2):210. https://doi.org/10.1097/00000658-199902000-00008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. https://doi.org/10.1053/j.gastro.2008.01.034

Article  PubMed  Google Scholar 

Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, Schirmacher P, Vilgrain V (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69(1):182–236. https://doi.org/10.1016/j.jhep.2018.03.019

Article  Google Scholar 

Ge PS, Runyon BA (2016) Treatment of patients with cirrhosis. N Engl J Med 375(8):767–777. https://doi.org/10.1056/nejmra1504367

Article  CAS  PubMed  Google Scholar 

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358–380. https://doi.org/10.1002/HEP.29086

Article  PubMed  Google Scholar 

Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY, Lee SD (2004) Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 10(17):2472–2477. https://doi.org/10.3748/WJG.V10.I17.2472

Article  PubMed  PubMed Central  Google Scholar 

Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K (2019) Increased risk for hepatocellular carcinoma persists up to 10 Years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores. Gastroenterology 157(5):1264-1278.e4. https://doi.org/10.1053/J.GASTRO.2019.07.033

Article  CAS  PubMed  Google Scholar 

Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y (2002) Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89(1):57–62. https://doi.org/10.1046/J.0007-1323.2001.01969.X

Article  CAS  PubMed  Google Scholar 

Liang B-Y, Gu J, Xiong M, Zhang E-L, Zhang Z-Y, Lau W-Y, Wang S-F, Guan Y, Chen X-P, Huang Z-Y (2022) Histological severity of cirrhosis influences surgical outcomes of hepatocellular carcinoma after curative hepatectomy. J Hepatocell Carcinoma 9:633–647. https://doi.org/10.2147/JHC.S368302

Article  PubMed  PubMed Central  Google Scholar 

Lim JK, Flamm SL, Singh S, Falck-Ytter YT, Gerson L, Hirano I, Nguyen GC, Rubenstein JH, Smalley WE, Stollman N, Sultan S, Vege SS, Wani SB, Weinberg D, Yang YX (2017) American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis. Gastroenterology 152(6):1536–1543. https://doi.org/10.1053/J.GASTRO.2017.03.017

Article  PubMed  Google Scholar 

Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 53(3):726–736. https://doi.org/10.1002/HEP.24105

Article  PubMed  Google Scholar 

Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–337. https://doi.org/10.1055/S-2007-1007122

Article  CAS  PubMed  Google Scholar 

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP (2010) Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59(9):1265–1269. https://doi.org/10.1136/GUT.2010.216077

Article  PubMed  Google Scholar 

Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S (2008) Extrahepatic cholestasis increases liver stiffness (fibroScan) irrespective of fibrosis. Hepatology 48(5):1718–1723. https://doi.org/10.1002/HEP.22577

Article  PubMed  Google Scholar 

Ouyang GX, Zhang Y, Mei ZS, Wang P, Ren Y, Li JH, Liu YK, Chen J, de Xiang B, Li L, Liu JY, Zhang ZM (2018) A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep. https://doi.org/10.1038/S41598-018-31351-3

Article  PubMed  PubMed Central  Google Scholar 

Sagir A, Erhardt A, Schmitt M, Häussinger D (2008) Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47(2):592–595. https://doi.org/10.1002/HEP.22056

Article  CAS  PubMed  Google Scholar 

Schrecker C, Waidmann O, El Youzouri H, Trojan J, Schnitzbauer AA, Bechstein WO, Zeuzem S, Koch C (2022) Low Platelet count predicts reduced survival in potentially resectable hepatocellular carcinoma. Curr Oncol 29(3):1475–1487. https://doi.org/10.3390/CURRONCOL29030124

Article  PubMed  PubMed Central  Google Scholar 

Shaheen AAM, Myers RP (2007) Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 46(3):912–921. https://doi.org/10.1002/HEP.21835

Article  PubMed  Google Scholar 

Sheth SG, Flamm SL, Gordon FD, Chopra S (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 93(1):44–48. https://doi.org/10.1111/J.1572-0241.1998.044_C.X

Article  CAS  PubMed  Google Scholar 

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43(6):1317–1325. https://doi.org/10.1002/HEP.21178

Article  CAS  PubMed  Google Scholar 

Suh B, Park S, Shin DW, Yun JM, Yang HK, Yu SJ, Shin CI, Kim JS, Ahn E, Lee H, Park JH, Cho B (2015a) High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology 61(4):1261–1268. https://doi.org/10.1002/HEP.27654

Article  CAS  PubMed  Google Scholar 

Suh B, Yun JM, Park S, Shin DW, Lee TH, Yang HK, Ahn E, Lee H, Park JH, Cho B (2015b) Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Cancer 121(21):3818–3825. https://doi.org/10.1002/CNCR.29577

Article  CAS  PubMed  Google Scholar 

Tapper EB, Lok AS-F (2017) Use of liver imaging and biopsy in clinical practice. N Engl J Med 377(8):756–768. https://doi.org/10.1056/nejmra1610570

Article  PubMed  Google Scholar 

Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 142(5):685–694. https://doi.org/10.1016/j.surg.2007.05.009

Article  PubMed  Google Scholar 

Trevethan, R. (2017). Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice. Frontiers in Public Health, 5. https://doi.org/10.3389/FPUBH.2017.00307

Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380(15):1450–1462. https://doi.org/10.1056/NEJMRA1713263

Article  CAS